Hypertension Aging
Conditions
Interventions
This is a randomized controlled, crossover, superiority clinical trial protocol with blinded data analysis, involving elderly hypertensive women from the community. The same sample will undergo two ex
Sponsors
Universidade Federal do Rio Grande do Sul
Universidade Federal do Rio Grande do Sul
Eligibility
Sex/Gender
Female
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Women aged 65 or older; diagnosed with hypertension or undergoing pharmacological treatment with antihypertensive drugs; not having participated in regular physical exercise programs in the last three months; presenting a medical certificate attesting to their readiness to perform light to moderate intensity physical exercise. Instructors must have completed courses that included this modality in their curriculum
Exclusion criteria
Exclusion criteria: Previous diagnosis of ischemic heart disease; heart failure; moderate to severe chronic obstructive pulmonary disease; diabetes mellitus with peripheral neuropathy; musculoskeletal conditions that prevent them from exercising or presenting with unhealed wounds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A reduction of approximately 5 mmHg in ambulatory systolic blood pressure is expected after the exercise session compared to the control session. The outcome will be assessed using 24-hour ambulatory blood pressure monitoring (ABPM), employing a validated and calibrated device with automatic recordings at predetermined intervals throughout the monitoring period. Mean systolic blood pressure values obtained over 24 hours, during both wakefulness and sleep periods, will be analyzed. The outcome will be considered achieved when an average difference of approximately 5 mmHg is identified between the experimental and control conditions | — |
Secondary
| Measure | Time frame |
|---|---|
| No significant reduction in ambulatory diastolic blood pressure is expected after the exercise session compared to the control session. The outcome will be assessed using 24-hour ambulatory blood pressure monitoring (ABPM), employing a validated and calibrated device with automatic recordings at predetermined intervals throughout the monitoring period. Mean diastolic blood pressure values obtained over 24 hours, during both wakefulness and sleep periods, will be analyzed. The absence of a significant effect will be considered when no statistically relevant differences are identified between the experimental and control conditions;A reduction of approximately 5 mmHg in daytime systolic blood pressure is expected after the exercise session compared to the control session. The outcome will be assessed using 24-hour ambulatory blood pressure monitoring (ABPM), employing a validated and calibrated device with automatic recordings at predetermined intervals throughout the wakefulness period. Mean systolic blood pressure values obtained during the daytime period will be analyzed. The outcome will be considered achieved when an average difference of approximately 5 mmHg is identified between the experimental and control conditions;A reduction of approximately 5 mmHg in nighttime systolic blood pressure is expected after the exercise session compared to the control session. The outcome will be assessed using 24-hour ambulatory blood pressure monitoring (ABPM), employing a validated and calibrated device with automatic recordings at predetermined intervals throughout the sleep period. Mean systolic blood pressure values obtained during the nighttime period will be analyzed. The outcome will be considered achieved when an average difference of approximately 5 mmHg is identified between the experimental and control conditions;A reduction of approximately 2 mmHg in mean arterial pressure is expected after the exercise session compared to the control session. The outcome will be | — |
Countries
BR
Contacts
Public ContactAna Kanitz
Universidade Federal do Rio Grande do Sul
Outcome results
None listed